This compound is a deuterium-labeled intermediate used in the synthesis of alcaftadine. It features a tricyclic benzazepine core with a piperidine substituent and a formyl group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4-Amino-N-(1-ethyl-3-piperidinyl)-5-(ethylsulfonyl)-2-methoxybenzamide-d5
pharmaceutical intermediate
Bambuterol-d9 Hydrochloride
pharmaceutical intermediate
(2,6-difluorophenyl)methanesulfonyl Chloride
pharmaceutical intermediate
3-methyl-1-(tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-amine hydrochloride
pharmaceutical intermediate
Alcaftadine
pharmaceutical raw material
Alcaftadine 3-Carboxylic Acid-d3
pharmaceutical intermediate
Alcaftadine carboxylic acid
pharmaceutical raw material
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine
pharmaceutical raw material
11-[1-(trideuteriomethyl)piperidin-4-ylidene]-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde
MWTBKTRZPHJQLH-FIBGUPNXSA-N
[2H]C([2H])([2H])N1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.